FOLLOW US ON... FEEDBACK

Home >> Industry News >> Product News
frontview no frame frontview vmo3D sideview no frame sideview vmo3D
Product News
  • Also available via:


Hoet Eyewear Launches New Collections PDF
Submit Your News
Product News
Friday, 26 April 2013

Born out of the irrepressible drive to renew. The search for perfect simplicity, chic, elegance, something unique. Timeless design with a personality that is both classic and modern; perhaps somewhat sober, but definitely not commonplace. Hoet eyewear are limited editions.

AnnaAmos

The latest additions are new optical frames in the Albane collection, called Anna and Amos. The elegant line of the frame that flows seamlessly over into the glass continues to be innovative and timeless. True to tradition, the models are available in 3 colours: natural, gold and black.

Hoet eyewear has also introduced the new sunglasses Cabrio Evo B to its Cabrio range.Cabrio Evo B

 
"Carrera by Jimmy Choo" Eyewear Capsule Collection Announced PDF
Submit Your News
Product News
Friday, 19 April 2013

Carrera, a leading brand of Safilo Group and the iconic luxury fashion brand Jimmy Choo recently announced an agreement for the design, production and distribution of an exclusive capsule collection of Carrera by Jimmy Choo sunglasses. The collection will blend the eyewear expertise and bold attitude of Carrera with the epitome of style and glamour which is Jimmy Choo in a range of unique models combining high performance in a fashion forward aesthetic.

“We are extremely excited about this partnership which we know will result in the creation of an exceptional product,” said Pierre Denis, CEO of Jimmy Choo. "The Carrera brand, since its creation in 1956, has forged a unique position in the eyewear sector and is recognized for being both innovative and adventurous. We are proud to associate Jimmy Choo with Carrera in this limited collection of eyewear." "The aspirational nature of all Jimmy Choo products confirms its position as one of the leading luxury accessory brands in the world. It embodies the essential elements that women aspire to: empowered glamour which is a bit rebellious," commented Roberto Vedovotto, CEO of Safilo Group. "The Carrera by Jimmy Choo collection will represent the perfect union of these elements with the determination and boldness of Carrera."

 
PROLENSA Solution Approved By FDA PDF
Submit Your News
Product News
Thursday, 18 April 2013

Bausch + Lomb announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for PROLENSA™ (bromfenac ophthalmic solution) 0.07 percent prescription eye drop, an innovative once-daily nonsteroidal anti-inflammatory drug (NSAID) for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery. PROLENSA will be available in 1.6ml and 3ml bottle sizes. PROLENSA provides powerful and rapid resolution of inflammation and pain by leveraging the unique potency of the bromfenac molecule in a formulation designed to facilitate ocular penetration. The advanced formulation allows for a lower concentration of bromfenac in a once daily dosing regimen. PROLENSA is a solution that does not require shaking to deliver a consistent dose in each drop.

The efficacy of PROLENSA was evaluated in two randomized, double-masked, vehicle-controlled studies of patients undergoing cataract surgery. Each randomized patient received PROLENSA or vehicle starting with one drop into the surgical eye on the day prior to and the day of surgery, and for 14 days following surgery. The primary efficacy endpoint was complete clearing of ocular inflammation (assessed by the summed ocular inflammation score, SOIS, which includes cells and flare) by day 15. The secondary efficacy endpoint was the number of subjects that were pain free on day one after surgery.

Results from the pivotal studies demonstrated PROLENSA to be superior to vehicle in the treatment of both inflammation and pain following cataract surgery. Twice as many patients as vehicle (46 percent versus 20 percent) demonstrated complete clearance of inflammation (SOIS of 0) at day 15. The difference in the average post-operative inflammation severity between the treatment and vehicle arms was statistically and clinically significant by day eight. Nearly four of five patients treated with PROLENSA were pain free at day one (78.8 percent versus 49.5 percent for vehicle; p<0.0001). Patients treated with PROLENSA reported a lower incidence of foreign body sensation and photophobia and had less redness than those treated with vehicle.

 
FDA Clears iPhone Vision Test App PDF
Submit Your News
Product News
Thursday, 11 April 2013

myVisionTrackThe U.S. Food and Drug Administration (FDA) has cleared to market myVisionTrack™, a prescription-only medical device that enables patients with retinal diseases to monitor their vision function between regular visits to their eye-care professional to help ensure they obtain timely care and treatments.

Using a proprietary patented shape discrimination hyperacuity (SDH) test, myVisionTrack™ enables patients to regularly assess their vision function. The device stores test results, tracks disease progression and automatically alerts a health care provider if it suspects significant deterioration of visual function in the patient.

Age-related macular degeneration (AMD), diabetic retinopathy (DR) and other retinal diseases afflict more than 40 million people in countries with advanced health care systems. Roughly 13 million people suffer from these diseases in the United States. During the past decade, new therapies have been developed for these degenerative eye diseases, but timely diagnosis and treatment are critical to their effectiveness.

Clinical studies demonstrate that myVisionTrack™'s shape discrimination hyperacuity test has comparable or higher sensitivity and specificity as compared to clinically available standard visual function tests for detecting advanced maculopathy from high-risk moderate maculopathy.

myVisionTrack™ can be used in a physician's office or at home by patients with maculopathy to help track disease progression, detect disease condition changes for earlier intervention and document treatment effects. Research confirms high satisfaction and compliance rates among patients able and willing to self-test at home with myVisionTrack™.

More information about myVisionTrack™ can be found at www.myvisiontrack.com.

 
Benner Launches New Cosmo Duo Collection PDF
Submit Your News
Product News
Monday, 08 April 2013

Cosmo Duo 1 After a very successful launch and distribution of the Cosmo metal collection in 2012, Benner is proud to unveil Cosmo Duo this spring. One of the most unique features of the Cosmo collection is the huge variety of colour combinations. Combining a base colour with a top colour and selecting the effect how this top-colour is painted, all Cosmo styles offer a wide range of looks from discreet to funky just by choosing a more calm or original colour combination.

The colour variety that can be chosen for every style plus the great adjustability were the design-base when creating Cosmo Duo. But now with the addition of an extra material: Acetate!

Cellulose acetate parts were connected to a fine metal "skeleton" using a nylon wire. This gives the frame sturdiness and flexibility at the same time. The metal part of the frames come in the same seven colours like the metal Cosmos, the acetate comes in three colours. Also there's a choice of having a mat or a shiny surface for the acetate rings.

Combining all these option it comes to a choice of 42 different combinations and again, through the very wearable shapes the styles range from calm to funky, just by choosing the colour of the metal and acetate parts.Like the metal Cosmo collection, the full frame is completely made in Germany near Stuttgart.

Cosmo Duo 2Cosmo Duo 3

The launch of the new collection at the recently held Vision Expo East has received great attention.

 
Harley-Davidson Launches New Premuim Eyewear Line PDF
Submit Your News
Product News
Wednesday, 03 April 2013

Harley-Davidson Performance Eyewear by Wiley X launched in 2012 with an initial collection 32 styles. In 2013 a second launch of 10 Harley-Davidson-exclusive frame/lens combinations are also available to motorcycle enthusiasts everywhere through the worldwide Harley-Davidson® dealer network.

“Our riders expect the highest quality riding gear from the Motor Company,” said Patrick Smith, Vice President of General Merchandise, Harley-Davidson Motor Company. “Partnering with Wiley X – an eyewear industry leader for 25 years – combines the strengths of both companies to give our customers the performance, features and styles that they demand.” Harley-Davison Eyewear

The original collection of 32 styles features the high-performance and protection demanded by active motorcyclists, including: virtually unbreakable frames and shatter resistant lenses; premium quality optics that eliminate glare and harmful UVA/UVB rays; and Wiley X’s patented, removable soft Facial Cavity seal that conforms to the face to block wind, dust and debris. This eyewear delivers a superior fit, comfort and style both on and off the motorcycle.

Additionally, select new styles feature Harley-Davidson exclusive PPZ™ lens technology (Partial Polarized) with 70-percent polarization that cuts glare and reflection without compromising the vision that differentiates between water, oil, ice and contours of the road. PPZ technology is available in the following Climate Control Series: AirRage, Brick, Echo, Gravity and new HD® Gem.

 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 7 of 44